Invitae appoints technology and medtech veteran Roxi Wen as chief financial officer

SAN FRANCISCO: SAN FRANCISCO, June 11, 2021 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced the appointment of Roxi Wen as its chief financial officer, effective June 21, 2021. Wen brings decades of success as a senior financial executive where she scaled global technology and medical...

Click to view original post